<DOC>
	<DOCNO>NCT03056300</DOCNO>
	<brief_summary>The primary objective trial demonstrate effectiveness power vascular stapler transection pulmonary artery ( PA ) pulmonary vein ( PV ) Video-Assisted Thoracoscopic Lobectomy .</brief_summary>
	<brief_title>A Prospective , Multi-Center Evaluation Powered Vascular Stapler Video-Assisted Thoracoscopic Lobectomies</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Subjects confirm suspected diagnosis stage IA stage IIB nonsmall cell lung cancer schedule lobectomy ( Lung Cancer Staging per American Joint Committee Cancer,7th Edition ) 7 ; 2 . Subjects schedule VATS lobectomy accordance institution 's SOC ; 3 . Performance status 01 ( Eastern Cooperative Oncology Group classification ) ; 4 . ASA score &lt; 3 ; 5 . No prior history VATS open lung surgery ( lung procedure perform ) ; 6 . Willing give consent comply studyrelated evaluation treatment schedule ; 7 . 1875 year age ( inclusive ) . 1 . Active ( subject currently receive systemic treatment ) bacterial infection fungal infection ; 2 . Systemic administration ( intravenous oral ) steroid , include herbal supplement contain steroid ( within 30 day prior study procedure ) ; 3 . Uncontrolled diabetes mellitus ; 4 . End stage renal liver disease ; 5 . History severe cardiovascular disease ; 6 . FEV1 % &lt; 50 % severe COPD ; 7 . Prior chemotherapy radiation lung cancer ; 8 . Scheduled concurrent surgical procedure diagnostic wedge resection follow lobectomy ( central venous access e.g. , port placement , mediastinoscopy lymph node sampling , VATS lymphadenectomy allow ) ; 9 . Roboticassisted procedure ; 10 . Women pregnant lactating time screening ; 11 . Physical psychological condition would impair study participation ; 12 . The subject judge unsuitable study participation Investigator reason ; 13 . Participation investigational drug ( within 30 day 5 halflives investigational drug ) device study ; 14 . Unable unwilling attend followup visit examination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>